AXO-Lenti-PD

Focused on rebuilding the pipeline, Axovant’s new crew assembles another preclinical gene therapy deal
Endpoints
Mon, 07/9/18 - 10:55 am
Axovant Sciences
AXO-Lenti-PD
gene therapy
RNAi
Benitec
Axovant Bets on Gene Therapy With $842 Million Deal With Oxford BioMedica
CP Wire
Wed, 06/6/18 - 09:29 am
Axovant
Oxford BioMedica
AXO-Lenti-PD
Pro-Savin